Atlas Trials

Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD

Clinical trial NCT04655170 · COMPLETED

Trial details

NCT number
NCT04655170
Sponsor
University of Tennessee Graduate School of Medicine
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COPD Exacerbation
Start date
2020-12-09
Primary completion
2023-01-19
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.